Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

NCT05745961 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05745961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05745961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2023
Completion date
April 30, 2025
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, pulmonary arterial hypertension